GBA1 and Parkinson disease: Mutations in the glucocerebrosidase (GBA1) gene, encoding a lysosomal enzyme involved in sphingolipid degradation, are now recognized as the main genetic risk factor for PD and as a negative clinical prognostic factor [11–13].